These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26684255)

  • 21. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy.
    Han SS; Na KY; Chae DW; Kim YS; Kim S; Chin HJ
    Tohoku J Exp Med; 2010 Jun; 221(2):133-40. PubMed ID: 20495302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen, plasminogen activator inhibitor-1, and carotid intima-media wall thickness in the NHLBI Family Heart Study.
    Folsom AR; Pankow JS; Williams RR; Evans GW; Province MA; Eckfeldt JH
    Thromb Haemost; 1998 Feb; 79(2):400-4. PubMed ID: 9493598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between serum adipocyte fatty acid-binding protein and endothelial/hemostatic markers in dyslipidemic subjects.
    Karasek D; Vaverkova H; Frysak Z; Orsag J; Novotny D; Halenka M; Slavik L
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():26-31. PubMed ID: 23183506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between serum total bilirubin level and leukoaraiosis in Korean adults.
    Park BJ; Shim JY; Lee HR; Kang HT; Lee JH; Lee YJ
    Clin Biochem; 2012 Mar; 45(4-5):289-92. PubMed ID: 22245549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of serum calcium concentrations with fibrinogen and homocysteine in nondiabetic Korean subjects.
    Cho HS; Lee SW; Shin J; Moon SD; Han JH; Cha BY; Kim ES
    Medicine (Baltimore); 2016 Jun; 95(24):e3899. PubMed ID: 27310988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents.
    Lin LY; Kuo HK; Hwang JJ; Lai LP; Chiang FT; Tseng CD; Lin JL
    Atherosclerosis; 2009 Apr; 203(2):563-8. PubMed ID: 18775539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
    Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
    Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
    Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
    Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efffect of plasminogen activator inhibitor-1 and endothelin-1 on the atherosclerosis in the maintenance hemodialysis patients].
    Ouyang L; Peng Y; Wu G; Xu X; He Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):458-67. PubMed ID: 23719522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
    Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
    Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Festa A; Goodarzi MO; Stefanovski D; Olson NC; Norris JM; Rewers MJ; Hanley AJ
    Diabetologia; 2013 Jan; 56(1):112-20. PubMed ID: 23052060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.